
|Articles|November 16, 2017
Singapore Market Expects to Reach $1.15 billion by 2021
Advertisement
The Singapore pharmaceutical market is predicted to grow from $903 million in 2016 to $1.15 billion by 2012, according to data and analytics company GlobalData.
The company’s latest report shows that a key driver in Singapore’s healthcare market is universal access to health insurance and world-class biomedical sciences research facilities.
The medical device market is expected to grow as Singapore strengthens its position as the region’s healthcare hub. In 2015, the medical device market contributed $1.69 billion to Singapore’s output.
View the full report
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5




